Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
Carlo G. Tocchetti(Federico II University Hospital), Alexander R. Lyon(Royal Brompton Hospital), Teresa López‐Fernández(Hospital Universitario La Paz), Liam S. Couch(The Task Force for Global Health), Javid J. Moslehi(University of California, San Francisco), Christine Brezden‐Masley(Mount Sinai Hospital), Daniela Cardinale, Pietro Ameri(Ospedale Policlinico San Martino), Ana Barac(National Institute of Dental and Craniofacial Research), Rudolf A. de Boer(University Medical Center Groningen), Ciro Santoro(Federico II University Hospital), Mariana Mirabel, Chris Plummer(Newcastle upon Tyne Hospitals NHS Foundation Trust), Daniel J. Lenihan(Saint Francis Medical Center), Susan Dent(Government of the United States of America), María Sol Andrés(Royal Brompton & Harefield NHS Foundation Trust), Christoph Maack(Comprehensive Cancer Center Mainfranken), Amam Mbakwem(University of Lagos), Luigi Formisano(University of Naples Federico II), Andrew J.S. Coats(IRCCS Ospedale San Raffaele), Aaron L. Sverdlov(Hunter New England Local Health District), Jeroen J. Bax(Netherlands Heart Institute), Marco Metra(GoHypersonic (United States)), Fabrizio Pane(Ceinge Biotecnologie Avanzate (Italy)), Michael G. Fradley(University of South Florida), Sivatharshini Ramalingam(Royal Brompton & Harefield NHS Foundation Trust), Dimitrios Farmakis, Lewis Au(Royal Marsden NHS Foundation Trust), Max Emmerich(St Thomas' Hospital), Esther Lutgens(Institute for Sports Medicine), Tienush Rassaf(West German Heart and Vascular Center Essen), Riccardo Asteggiano, Paaladinesh Thavendiranathan(University of Toronto), Jutta Bergler‐Klein, Petar Seferović, Alain Cohen‐Solal(Hôpital Lariboisière), Bonnie Ky(Washington Hospital), Emilio Hirsch(University of Turin), Hadi Skouri(American University of Beirut Medical Center), Tomas G. Neilan(Duke Medical Center), Kalliopi Keramida(National and Kapodistrian University of Athens), Geeta Gulati(Oslo University Hospital), Gilles W. De Keulenaer(University of Antwerp), Joerg Herrmann(Mayo Clinic), Fortunato Ciardiello(University of Campania "Luigi Vanvitelli"), Thomas Suter, Peter van der Meer(University Medical Center Groningen), Giuseppe Rosano(Vita-Salute San Raffaele University), Yvonne Koop(Utrecht University), Zaza Iakobishvili(Tel Aviv University)
Cited by 64
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k